Simon Krols ORCID iD 0000-0001-9053-082X 1 – 3 of 3 publications Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Filter publications Download search results Subscribe to news feed Add to list Journal Article A1 open access Dual N6/C7-substituted 7-deazapurine and tricyclic ribonucleosides with affinity for G protein-coupled receptors Simon Krols (UGent) , Federica Matteucci, Kristof Van Hecke (UGent) , Guy Caljon, Kenneth A. Jacobson and Serge Van Calenbergh (UGent) (2023) ACS MEDICINAL CHEMISTRY LETTERS. 15(1). p.81-86 Add to list Journal Article A1 open access Targeted AURKA degradation : towards new therapeutic agents for neuroblastoma Muhammad Rishfi (UGent) , Simon Krols (UGent) , Fien Martens (UGent) , Sarah-Lee Bekaert (UGent) , Ellen Sanders (UGent) , Aline Eggermont (UGent) , Fanny De Vloed (UGent) , Joshua Robert Goulding (UGent) , Martijn Risseeuw (UGent) , Jan Molenaar, et al. (2023) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 247. Add to list Journal Article A1 open access Efficient divergent synthesis of new immunostimulant 4″-modified α-galactosylceramide analogues Jonas Janssens, Tine Decruy (UGent) , Koen Venken (UGent) , Toshiyuki Seki, Simon Krols (UGent) , Johan Van der Eycken (UGent) , Moriya Tsuji, Dirk Elewaut (UGent) and Serge Van Calenbergh (UGent) (2017) ACS MEDICINAL CHEMISTRY LETTERS. 8(6). p.642-647
0000-0001-9053-082X